GM Rice Could Fight Diarrhea

A genetically modified strain of rice produces an antibody that helps mice fight off rotaviruses.

Written byKate Yandell
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

WIKIMEDIA, FRITZ GELLER-GRIMMGenetically modified rice could help protect children and the immuno-compromised from diarrheal disease, according to a study published last week (August 8) in The Journal of Clinical Investigation. More than 600,000 children die of rotavirus infections each year, and researchers say the rice could eventually supplement currently available vaccines and other treatments to reduce the rates of rotavirus-related death.

To produce their virus-fighting rice, the researchers inserted genes from llamas in order to get the plants to produce a key section of a rotavirus-targeting antibody, MucoRice-ARP1. This antibody fragment survives digestion, making oral administration possible.

The researchers tested the product in mice, giving them water mixed with rice powder before inoculating the animals with rotavirus. The mice that had received the genetically modified rice water had less diarrhea and a lower viral load than those not given the treatment.

There are already two vaccines available for rotavirus, but they have relatively low efficacy, possibly because they do not work well in immuno-compromised individuals. The researchers suggest that their GM rice could supplement the vaccines, providing protection for the immuno-compromised and infants who are at ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies